Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001553338-25-000005

Director sold 8,367 shares at an average $67.65 ($566,038)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Waddill William D. · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-19 Sale : show line 1 in the form 10b5-1 −2,416 $66.66 $161,051 62,514 D
2025-12-19 Sale : show line 2 in the form 10b5-1 −5,451 $68.01 $370,723 57,063 D
2025-12-19 Sale : show line 3 in the form 10b5-1 −500 $68.53 $34,265 56,563 D
Open-market sales · 8,367 sh · avg $67.65 · $566,038
Loading xslF345X05/wk-form4_1766530901.xml…